NCT06193239View on ClinicalTrials.gov

Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)

PHASE2RecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

April 25, 2025

Study Completion Date

April 30, 2025

Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST

OWL-EVO1

EVOC probe

Trial Locations (9)

140 59

RECRUITING

Thomayer Hospital, Prague

H-1121

NOT_YET_RECRUITING

National Koranyi Institute for Pulmonology, Budapest

H-4032

RECRUITING

Department of Pulmonology, University of Debrecen, Debrecen

CB2 0AY

RECRUITING

Royal Papworth Hospital NHS Foundation Trust, Cambridge

M23 9LT

RECRUITING

Wythenshawe Hospital, Manchester

LE3 9QP

RECRUITING

Glenfield Hospital, Leicester

E1 1FR

NOT_YET_RECRUITING

Barts Health NHS Trust, London

W12 0HS

RECRUITING

Imperial Centre for Translational and Experimental Medicine, Imperial College, London

NR4 7UQ

RECRUITING

Quadram Institute, Norwich

Sponsors

Lead Sponsor

Owlstone Ltd
All Listed Sponsors
lead

Owlstone Ltd

INDUSTRY